Trial Profile
A Phase I and Pharmacokinetic Single Agent Study of Pazopanib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 May 2017
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 14 Mar 2012 Additional lead trial investigator (Shivaani Kummar) identified as reported by ClinicalTrials.gov.
- 14 Mar 2012 Additional lead trial investigator (Shivaani Kummar) identified as reported by ClinicalTrials.gov.
- 05 Mar 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.